Twin Capital Management Inc. Sells 2,328 Shares of CME Group Inc. $CME

Twin Capital Management Inc. reduced its stake in shares of CME Group Inc. (NASDAQ:CME) by 19.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,423 shares of the financial services provider’s stock after selling 2,328 shares during the quarter. Twin Capital Management Inc.’s holdings in CME Group were worth $2,597,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. OneDigital Investment Advisors LLC grew its stake in CME Group by 18.2% in the first quarter. OneDigital Investment Advisors LLC now owns 2,937 shares of the financial services provider’s stock worth $779,000 after purchasing an additional 452 shares in the last quarter. Wayfinding Financial LLC bought a new stake in shares of CME Group in the first quarter valued at about $25,000. Penserra Capital Management LLC lifted its stake in CME Group by 108.1% in the first quarter. Penserra Capital Management LLC now owns 5,343 shares of the financial services provider’s stock worth $1,416,000 after acquiring an additional 2,776 shares during the period. Envestnet Asset Management Inc. lifted its stake in CME Group by 3.3% in the first quarter. Envestnet Asset Management Inc. now owns 570,206 shares of the financial services provider’s stock worth $151,270,000 after acquiring an additional 18,098 shares during the period. Finally, Financial Counselors Inc. lifted its position in shares of CME Group by 12.2% in the 1st quarter. Financial Counselors Inc. now owns 4,245 shares of the financial services provider’s stock worth $1,126,000 after purchasing an additional 461 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the transaction, the director owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 14,043 shares of company stock worth $3,791,486 over the last 90 days. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME stock opened at $268.00 on Thursday. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market capitalization of $96.64 billion, a price-to-earnings ratio of 25.97, a PEG ratio of 4.41 and a beta of 0.38. The stock’s 50-day simple moving average is $265.57 and its 200-day simple moving average is $272.19.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the business earned $2.68 EPS. CME Group’s revenue for the quarter was down 3.0% on a year-over-year basis. As a group, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently issued reports on CME. Raymond James Financial cut their price objective on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a report on Monday, October 13th. Barclays reduced their price target on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 8th. The Goldman Sachs Group raised their price objective on CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a research report on Thursday, October 23rd. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday, October 13th. Finally, JPMorgan Chase & Co. raised their price target on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a report on Tuesday, October 14th. Eight investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $285.19.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.